Ladenburg Thalmann Upgrades Genomic Health Inc. (GHDX) to Buy
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Rating Summary:
3 Buy, 15 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
3 Buy, 15 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Ladenburg Thalmann upgraded Genomic Health Inc. (NASDAQ: GHDX) from Neutral to Buy with a new price target of $26.00.
For more ratings news on Genomic Health Inc. click here and for the rating history of Genomic Health Inc. click here.
Shares of Genomic Health Inc. closed at $20.82 yesterday.
For more ratings news on Genomic Health Inc. click here and for the rating history of Genomic Health Inc. click here.
Shares of Genomic Health Inc. closed at $20.82 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
- Jefferies Upgrades Symrise AG (SY1:GR) (SYIEY) to Buy
- Piper Sandler Upgrades Capricor Therapeutics (CAPR) to Overweight 'Ahead of Extended 11/22 PDUFA Date'
Create E-mail Alert Related Categories
UpgradesRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
